Karnataka's bio-economy, currently valued at $ 24.4 billion contributing 33% of the national share, is on course to achieve $ 50 billion by...

GS Krishnan, formerly regional president & MD, Novozymes South Asia Pvt Ltd, a Danish biotech company, has taken charge as the new Presiden...

Marcel Ravin at Vetro, The Oberoi, in Mumbai from Sept 26-29, 2019.

'Many pharmaceutical companies have established R&D centers in India and are considering tapping India’s talent', says Lawrence Ganti.

US-based biotechnology firm Life Technologies today said it will hire up to 100 people in India by the end of next fiscal.

Mumbai outpaced Bangalore, with a margin of about Rs 200 crore, to become India's top biotech city in terms of revenue.

Bangalore-based Avesthagen has revived its IPO plans. The company, which has four business divisions — biopharmaceuticals, bionutrition, bi...

The company, which has four business divisions - biopharmaceuticals, bionutrition, bioagriculture and R&D - is planning to raise approximat...

India's healthcare industry is valued at about $23 billion, which is almost four per cent of the GDP and is expected to grow at 12-13 per c...

Leading biotech company Avesthagen and French plant breeding major Groupe Limagrain on Wednesday said they have jointly acquired majority s...

US-based private equity firm Jacob Ballas Capital (JBC) is close to buying a minority stake in Avestha Gengraine Technologies (Avesthagen),...

The Union commerce ministry has okayed, in principle, a special economic zone to be set up in Haryana's basmati bowl, comprising Karnal, Ka...